Edwards Lifesciences (NYSE:EW) Downgraded to “Hold” at StockNews.com
StockNews.com downgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a buy rating to a hold rating in a report released on Saturday. EW has been the subject of several other research reports. Stifel Nicolaus reduced their target price on shares of Edwards Lifesciences from $87.00 to $70.00 and set a hold rating for […]
More Stories
Enlight Renewable Energy (NASDAQ:ENLT) Shares Gap Down – What’s Next?
Enlight Renewable Energy Ltd (NASDAQ:ENLT – Get Free Report)’s share price gapped down before the market opened on Tuesday ....
DHJJ Financial Advisors Ltd. Decreases Stake in Invesco S&P 500 Low Volatility ETF (NYSEARCA:SPLV)
DHJJ Financial Advisors Ltd. cut its stake in shares of Invesco S&P 500 Low Volatility ETF (NYSEARCA:SPLV – Free Report)...
Riverwater Partners LLC Has $505,000 Stock Position in Sony Group Co. (NYSE:SONY)
Riverwater Partners LLC boosted its holdings in shares of Sony Group Co. (NYSE:SONY – Free Report) by 47.6% in the...
Nucor (NYSE:NUE) Price Target Lowered to $168.00 at JPMorgan Chase & Co.
Nucor (NYSE:NUE – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $170.00 to $168.00 in...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
Cantor Fitzgerald reiterated their overweight rating on shares of Pfizer (NYSE:PFE – Free Report) in a research report report published...
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Capital Investment Counsel Inc
Capital Investment Counsel Inc grew its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 16.9% in the third quarter,...